INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57801, 6933, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57802, 8209, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57803, 10139, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57804, 11112, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57805, 11403, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57806, 14060, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57807, 14204, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57808, 15171, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57809, 15173, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57810, 17014, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57811, 17974, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57812, 18649, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57813, 18982, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57814, 18996, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57815, 19254, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57816, 20005, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57817, 20006, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57818, 20168, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57819, 20170, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57820, 20173, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57821, 20175, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57822, 20176, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57823, 20606, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57824, 20895, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57825, 20970, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57826, 21834, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57827, 25047, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57828, 27837, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57829, 28533, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57830, 33550, 'Iron Dextran', 'Liver Diseases', 'Iron is transported in plasma complexed to transferrin, a beta1-glycoprotein synthesized by the liver.  Iron is cleared from the plasma by the reticuloendothelial system (including liver) and excess stored as ferritin within the reticuloendothelial system and hepatocytes.  Therapy with iron dextran should be administered with extreme caution in patients with severe hepatic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57831, 1408, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57832, 1784, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57833, 1827, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57834, 1852, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57835, 1883, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57836, 3088, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57837, 4215, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57838, 4663, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57839, 4813, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57840, 4814, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57841, 4859, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57842, 5394, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57843, 5862, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57844, 6287, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57845, 6288, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57846, 6694, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57847, 6826, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57848, 6933, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57849, 8209, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57850, 10139, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57851, 11112, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57852, 11403, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57853, 14060, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57854, 14204, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57855, 15171, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57856, 15173, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57857, 17014, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57858, 17974, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57859, 18649, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57860, 18982, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57861, 18996, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57862, 19254, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57863, 20005, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57864, 20006, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57865, 20168, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57866, 20170, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57867, 20173, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57868, 20175, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57869, 20176, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57870, 20606, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57871, 20895, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57872, 20970, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57873, 21834, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57874, 25047, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57875, 27837, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57876, 28533, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57877, 33550, 'Iron Dextran', 'Nervous System Diseases', 'Iron dextran has induced neurologic toxicity such as seizures, paresthesia, weakness, disorientation, and unconsciousness.  Therapy with iron dextran should be administered cautiously in patients with or predisposed to neurologic dysfunction.', '3', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57878, 1408, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57879, 1784, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57880, 1827, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57881, 1852, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57882, 1883, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57883, 3088, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57884, 4215, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57885, 4663, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57886, 4813, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57887, 4814, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57888, 4859, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57889, 5394, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57890, 5862, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57891, 6287, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57892, 6288, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57893, 6694, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57894, 6826, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57895, 6933, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57896, 8209, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57897, 10139, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57898, 11112, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57899, 11403, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (57900, 14060, 'Iron Dextran', 'Cardiomyopathies', 'Cardiac toxicity such as chest pain and tightness, shock, hypertension, tachycardia and arrhythmia have occurred during iron dextran therapy.  Hypotension and flushing have been reported and are thought to be infusion- rate related.  Adverse reactions experienced following therapy with iron dextran may exacerbate cardiovascular complications in patients with preexisting cardiovascular disease, caution is advised.', '2', '', 'DDInter', 0);
